… the molecular interactions of drugs with therapeutic indications for treatment of COVID-19
(… structures (Chloroquine, Quinacrine and Ruxolitinib) in docking models from the SARS-CoV-2 …

… to interact with selected COVID-19 proteins. The interaction of molecules with target NSPs
and their binding ability have been demonstrated by molecular docking studies. According to …

… [14] Docking with the COVID-19 Mpro in complex with the inhibitor N3 was explored in this
… [16] Therefore, docking of chloroquine and hydroxychloroquine with the COVID-19 Mpro (in …

… In the current spread of novel coronavirus (SARS-CoV-2), antiviral drug discovery is of … by
molecular docking with the structural protein and non-structural protein sites of new coronavirus…

… beginning of the COVID-19 pandemic. In this study, we carried out a virtual screening for
almost all members of ARBs (nine) against COVID-19 main protease. Molecular docking as one …

… study, using molecular docking, we identify new probable inhibitors of COVID-19 by molecules
… The discovery of the M pro protease structure in COVID-19 provides a great opportunity to …

… of COVID-19 can be a target protein of these nucleotides in silico using molecular docking.
… been established to investigate the effectiveness of the drugs as inhibitors for COVID 19. …

… to identify drugs for the treatment of COVID-19 [19]. Docking utilizes the structure of the
recep… Docking can also be used to screen a large number of receptors for potential binding to a …

… Although, several molecular docking studies have been established to find a potential …
for COVID-19 disease are available and investigations regarding the treatment of COVID-19 …

… potential COVID-19 Mpro inhibitors, using a molecular docking study. Molecular docking was
… Autodock 4.2, with the Lamarckian Genetic Algorithm, to analyse the probability of docking. …